Research - Initial Experience of Intravesical Gemcitabine for Patients With High-Risk Superficial Transitional Cell Carcinoma Of the Bladder Following BCG Failure

Research - Initial Experience of Intravesical Gemcitabine for Patients With High-Risk Superficial Transitional Cell Carcinoma Of the Bladder Following BCG Failure


Identification: unj_ma14_05
Issue: March-April 2014
Volume: Volume 34 Number 2


Credits

Credits: None available.